Daihan Pharmaceutical Co.Ltd Financial Flexibility Index
Daihan Pharmaceutical Co.Ltd financial flexibility index. Daihan Pharmaceutical Co.Ltd (023910) has a Financial Flexibility Index of 0.40x as of September 2025. Free cash flow of ₩20.27 Billion (operating CF ₩9.47 Billion minus capex ₩10.79 Billion) represents 0% of total liabilities (₩50.75 Billion). Explore capital reinvestment ratio of Daihan Pharmaceutical Co.Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Daihan Pharmaceutical Co.Ltd (2014–2024)
Financial flexibility index of Daihan Pharmaceutical Co.Ltd from 2014 to 2024. Historical Financial Flexibility Index trend for Daihan Pharmaceutical Co.Ltd across 11 annual periods. Check Daihan Pharmaceutical Co.Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Daihan Pharmaceutical Co.Ltd Financial Flexibility Index by Year (2014–2024)
Daihan Pharmaceutical Co.Ltd financial flexibility index by year from 2014 to 2024. Year-by-year free cash flow to debt coverage for Daihan Pharmaceutical Co.Ltd. For the full cash flow conversion analysis, see 023910 operating cash flow.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.06x | ₩51.44 Billion | ₩35.64 Billion | ₩48.42 Billion | ▼ -18.2% |
| 2023 | 1.30x | ₩60.14 Billion | ₩38.86 Billion | ₩46.28 Billion | ▲ +78.2% |
| 2022 | 0.73x | ₩37.62 Billion | ₩29.00 Billion | ₩51.58 Billion | ▼ -3.1% |
| 2021 | 0.75x | ₩52.47 Billion | ₩40.62 Billion | ₩69.73 Billion | ▲ +37.3% |
| 2020 | 0.55x | ₩38.99 Billion | ₩33.63 Billion | ₩71.17 Billion | ▼ -16.5% |
| 2019 | 0.66x | ₩52.57 Billion | ₩35.26 Billion | ₩80.08 Billion | ▼ -32.4% |
| 2018 | 0.97x | ₩91.63 Billion | ₩44.94 Billion | ₩94.39 Billion | ▲ +60.3% |
| 2017 | 0.61x | ₩41.50 Billion | ₩20.45 Billion | ₩68.52 Billion | ▼ -18.1% |
| 2016 | 0.74x | ₩49.82 Billion | ₩27.92 Billion | ₩67.36 Billion | ▲ +109.0% |
| 2015 | 0.35x | ₩21.94 Billion | ₩17.98 Billion | ₩61.99 Billion | ▲ +19.7% |
| 2014 | 0.30x | ₩19.95 Billion | ₩9.48 Billion | ₩67.52 Billion | — |